Prescription opioid use in the rural Appalachia: A community-based study

Jennifer R. Havens, PhD, MPH; Robert Walker, MSW, LCSW; Carl G. Leukefeld, DSW

doi:10.5055/jom.2008.0010

Authors

Jennifer R. Havens, PhD, MPH
Robert Walker, MSW, LCSW
Carl G. Leukefeld, DSW

DOI:

https://doi.org/10.5055/jom.2008.0010

Keywords:

rural, Appalachia, pain, opioid

Abstract

Objective: The purpose of this study is to describe the sample characteristics and methods for a study of rural medical and nonmedical prescription opioid users with a history of OxyContin® use.
Design and Setting: Snowball sampling was used to recruit 221 rural Appalachian residents. Participants included those under medical supervision for pain (n = 101) as well as those self-reporting nonmedical use of prescription opioids (n = 120). Participants were given an interviewer-administered questionnaire.
Outcome measures: Data relating to demographics, illicit and nonmedical prescription drug use, medical, legal, family, and psychiatric status, as well as pain history were collected. The primary outcomes of interest were differences in past 30 day prescription drug use between pain patients and nonmedical opioid users.
Results: A significantly greater proportion of those treated for pain reported using oxycodone and hydrocodone prescribed by a physician in the prior 30 days (p < 0.001); however, more than third of pain participants also reported nonmedical use of OxyContin®, methadone, hydrocodone, benzodiazepines, and marijuana in the prior 30 days.
Conclusions: A large proportion of rural opioid users who reported being treated for pain also reported nonmedical use of prescription drugs. Similarly, among the nonmedical users, half of those reported experiencing pain that interfered with their daily life. These results suggest that many rural prescription drug users are being either incorrectly or perhaps inadequately treated for chronic nonmalignant pain. Therefore, developing educational materials and training for rural physicians about pain treatment (including drug seeking behavior) is proposed.

Author Biographies

Jennifer R. Havens, PhD, MPH

Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, Kentucky.

Robert Walker, MSW, LCSW

Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, Kentucky.

Carl G. Leukefeld, DSW

Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, Kentucky.

References

Substance Abuse and Mental Health Services Administration (SAMHSA): National Survey on Drug Use and Health 2002. Rockville, MD: SAMHSA, 2002.

Substance Abuse and Mental Health Services Administration (SAMHSA): National Household Survey on Drug Abuse, 2000. Rockville, MD: SAMHSA, 2000.

Substance Abuse and Mental Health Services Administration (SAMHSA): National Survey on Drug Use and Health, 2004. Rockville, MD: SAMHSA, 2004.

Substance Abuse and Mental Health Services Administration (SAMHSA): National Survey on Drug Use and Health, 2005. Rockville, MD: SAMHSA, 2006.

Substance Abuse and Mental Health Services Administration (SAMHSA): Oxycodone, Hydrocodone, and Polydrug use, 2002. Rockville, MD: SAMHSA, 2004.

Substance Abuse and Mental Health Services Administration (SAMHSA): National Survey on Drug Use and Health, 2003. Rockville, MD: SAMHSA, 2003.

Wunsch MJ, Nakamoto K, Goswami A, et al.: Prescription drug abuse among prisoners in rural Southwestern Virginia. J Addict Dis. 2007; 26(4): 15-22.

Havens JR, Oser CB, Leukefeld CG: Increasing prevalence of prescription opiate misuse over time among rural probationers. J Opioid Manag. 2007; 3(2): 107-111.

Havens JR, Oser CB, Leukefeld CG, et al.: Differences in prevalence of prescription opiate misuse among rural and urban probationers. Am J Drug Alcohol Abuse. 2007; 33(2): 309-317.

Substance Abuse and Mental Health Services Administration (SAMHSA): Treatment Admissions in Urban and Rural Areas Involving Abuse of Narcotic Painkillers. Rockville, MD, SAMHSA, 2004.

Knudsen HK, Ducharme LJ, Roman PM: Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics. J Addict Dis. 2007; 26(1): 41-50.

National Drug Intelligence Center: Kentucky drug threat assessment. Available at http://www.usdoj.gov/ndic/pubs1/1540/index.htm. Accessed July 2002.

Schoeneberger ML, Leukefeld CG, Hiller ML, et al.: Substance abuse among rural and very rural drug users at treatment entry. Am J Drug Alcohol Abuse. 2006; 32(1): 87-110.

Billings D, Blee K: Agriculture in the Kentucky mountains. In Pudup MB, Billings DB, Waller A (eds.). Appalachia in the Making: The Mountain South in the Nineteenth Century. Chapel Hill: University of North Carolina Press, 1995.

Maurer DW, Pearl Q: Kentucky Moonshine, 2nd ed. Lexington: University of Kentucky Press, 2003.

Potter G, Gaines LK, Holbrook B: Blowing smoke: An evaluation of marijuana eradication in Kentucky. Am J Police 1990; 9(1): 97-116.

Drug Enforcement Agency: State fact sheets, Kentucky 2007. Drug Enforcement Agency 2007; Available at http://www.dea.gov/pubs/states/kentucky.html. Accessed March 7, 2007.

Clayton RR: Marijuana in the “Third World”: Appalachia, U.S.A. Denver, CO: L. Reinner, 1995.

US Government Accounting Office: Prescription Drugs: OxyContin® Abuse and Diversion and Efforts to Address the Problem. Washington, DC: US Government Accounting Office, 2003. Report No.: GAO-04-110.

Food and Drug Administration: FDA Strengthens Warnings for OxyContin®. July 25, 2002. Available at http://www.fda.gov/cder/drug/infopage/oxycontin/. Accessed April 9, 2008.

Rosenberg D: How one town got hooked. Newsweek 2001; 137(15), 48-52.

Rosenberg D: Kentucky’s pain. Newsweek 2004; 144(12): 44-46.

Meier B: Pain Killer: A “Wonder” Drug’s Trail of Addiction and Death. New York: Rodale, 2003.

Barendregt C, van der PA, van de MD: Tracing selection effects in three non-probability samples. Eur Addict Res. 2005; 11(3): 124-131.

Hellard ME, Nguyen OK, Guy RJ, et al.: The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users. Aust N Z J Public Health. 2006; 30(6): 519-525.

Vervaeke HK, Korf DJ, Benschop A, et al.: How to find future ecstasy-users: Targeted and snowball sampling in an ethically sensitive context. Addict Behav. 2007; 32(8): 1705-13.

Hasnain M, Levy JA, Mensah EK, et al.: Association of educational attainment with HIV risk in African American active injection drug users. AIDS Care. 2007; 19(1): 87-91.

Appalachian Region: Counties in Appalachia. Appalachian Regional Commission 2004. Available at http://www.arc.gov/index.do?nodeId_27. Accessed September 1, 2004.

US Census Bureau: United States Census 2000. Available at http://quickfacts.census.gov/qfd/states/21000.html. Accessed September 1, 2004.

McLellan AT, Kushner H, Metzger D, et al.: The fifth edition of the addiction severity index. J Subst Abuse Treat 1992; 9(3): 199-213.

Kerns RD, Turk DC, Rudy TE: The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985; 23(4): 345-356.

Davis WR, Johnson BD: Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend 2008; 92(1/3): 267-276.

Wilsey BL, Fishman SM, Tsodikov A, et al.: Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med. 2008. In press. doi:10.1111/j.1526-4637.2007. 00400.x.

Carise D, Dugosh KL, McLellan AT, et al.: Prescription OxyContin® abuse among patients entering addiction treatment. Am J Psychiatry. 2007; 164(11): 1750-1756.

Huang B, Dawson DA, Stinson FS, et al.: Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006; 67(7): 1062-1073.

Edlund MJ, Sullivan M, Steffick D, et al.: Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Med. 2007; 8(8): 647-656.

Sullivan MD, Edlund MJ, Zhang L, et al.: Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006; 166(19): 2087-1093.

Sullivan MD, Edlund MJ, Steffick D, et al.: Regular use of prescribed opioids: Association with common psychiatric disorders. Pain. 2005; 119(1-3): 95-103.

Rosswurm MA, Dent DM, Rmstrong-Persily C, et al.: Illness experiences and health recovery behaviors of patients in southern Appalachia. West J Nurs Res. 1996; 18(4): 441-459.

Anglin MK, White JC: Poverty, health care, and problems of prescription medication: A case study. Subst Use Misuse. 1999; 34(14): 2073-1093.

Bushy A: Rural women. Lifestyle and health status. Nurs Clin North Am. 1993; 28(1): 187-197.

Mulder PL, Shellenberger S, Streigel R, et al: The Behavioral Healthcare Needs of Rural Women. Washington, DC: American Psychological Association, 2001.

Pelet A, Doll S, Huissoud T, et al.: Methadone maintenance treatment in the Swiss Canton of Vaud: demographic and clinical data on 1,782 ambulatory patients. Eur Addict Res. 2005; 11(2): 99-106.

Darke S, Ross J, Teesson M, et al.: Health service utilization and benzodiazepine use among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Addiction. 2003; 98(8): 1129-1135.

Bleich A, Gelkopf M, Schmidt V, et al.: Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic. Addiction. 1999; 94(10): 1533-1540.

Weizman T, Gelkopf M, Melamed Y, et al.: Treatment of benzodiazepine dependence in methadone maintenance treatment patients: A comparison of two therapeutic modalities and the role of psychiatric comorbidity. Aust N Z J Psychiatry. 2003; 37(4): 458-463.

Griffiths RR, Weerts EM: Benzodiazepine self-administration in humans and laboratory animalsÑImplications for problems of long-term use and abuse. Psychopharmacology (Berl). 1997; 134(1): 1-37.

Chan GM, Stajic M, Marker EK, ET AL.: Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: Analysis of medical examiner data. Acad Emerg Med. 2006; 13(5): 543-547.

Burrows DL, Hagardorn AN, Harlan GC, et al.: A fatal drug interaction between oxycodone and clonazepam. J Forensic Sci. 2003; 48(3): 683-686.

Jann MW, Slade JH: Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy. 2007; 27(11): 1571-1587.

Buskila D, Cohen H: Comorbidity of fibromyalgia and psychiatric disorders. Curr Pain Headache Rep. 2007; 11(5): 333-338.

O’Brien EM, Atchison JW, Gremillion HA, et al.: Somatic focus/awareness: Relationship to negative affect and pain in chronic pain patients. Eur J Pain. 2008; 12(1): 104-115.

Rikoon SH, Cacciola JS, Carise D, et al.: Predicting DSM-IV dependence diagnoses from Addiction Severity Index composite scores. J Subst Abuse Treat. 2006; 31(1): 17-24.